WIN 70197

Drug Profile

WIN 70197

Alternative Names: WIN-70197

Latest Information Update: 08 Sep 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Amersham Health; Sanofi Winthrop
  • Class Gadolinium-containing contrast agents; Radiopharmaceuticals
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Liver disorders

Most Recent Events

  • 08 Sep 2006 Discontinued - Preclinical for Liver disorders diagnosis in USA (unspecified route)
  • 16 Nov 1998 No development reported - Preclinical for Liver disorders diagnosis in USA (unspecified route)
  • 24 Jan 1997 Preclinical development for Liver disorders diagnosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top